RecruitingNCT07484971
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
Sponsor
Société Algérienne de Formation et Recherche en Oncologie
Enrollment
2,000 participants
Start Date
Jul 21, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer. It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Eligibility
Sex: MALEMin Age: 19 Years
Inclusion Criteria7
- Patients aged 19 years and older.
- Diagnosis of prostate cancer confirmed histologically and/or biologically.
- Patients followed in the participating oncology departments.
- Written informed consent obtained.
- Histological types other than carcinoma
- Secondary tumors
- Participation in an interventional study
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(24)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07484971
Related Trials
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
NCT058043188 locations
Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
NCT072011941 location
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT07028853329 locations
FOG-001 in Locally Advanced or Metastatic Solid Tumors
NCT0591926433 locations
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
NCT0678067081 locations